Browse Guides  internal medicine  gastroenterology

Upper gastrointestinal bleed

Prevalence
Causes
Clinical features
Investigations
Therapy
Prevention
Prognosis
Prevention

Ulcers and erosions

If patients need to continue NSAIDs, consider adding in a regular proton-pump inhibitor a  

Why?

  • Proton-pump inhibitors are more effective than placebo or H2 antagonists at preventing endoscopic ulcers. a Higher doses are more effective at controlling symptoms. a . There is no clear increased risk of stopping proton-pump inhibitors compared with placebo. a
  • Regular pantoprazole given to elderly patients on long-term NSAIDs leads to less severe gastrointestinal damage than a course of H.pylori eradication therapy. a Regular omeprazole leads to fewer recurrent GI bleeds than a course of eradication therapy for patients on naproxen, but not clearly for patients on low-dose aspirin. a

Long-term NSAIDs: proton-pump inhibitors prevent endoscopuc ulcers more effectively than placebo or H2-antagonists

Patient Treatment Comparison Outcome CER OR
(95% CI)
NNT
(95% CI)
on NSAIDs for > 3 weeks a proton-pump inhibitors placebo endoscopic gastric ulcers
at 3-12 months
21% 0.31
(0.20 to 0.48)
8
(6 to 10)
      endoscopic duodenal ulcers
at 3-12 months
11% 0.19
(0.10 to 0.36)
12
(10 to 15)
  proton-pump inhibitors H2-antagonists procedure required for uncontrolled bleeding/ rebleeding
at  days
21% 0.28
(0.16 to 0.48)
7
(6 to 11)

Omeprazole 40 mg reduces dyspepsia more effectively than omeprazole 20 mg.

Patient Treatment Comparison Outcome CER RRR
(95% CI)
NNT
(95% CI)
recently-healed peptic ulcer or erosions on regular NSAIDs a omeprazole 40 mg omeprazole 20 mg moderate to severe symptoms of dyspepsia
at 8 weeks
11% 45%
(6% to 68%)
20
(11 to 160)

Long-term NSAIDS: regular proton-pump inhibitors lead to less GI damage and fewer recurrent bleeds than eradication therapy 

Patient Treatment Comparison Outcome CER RRI
(95% CI)
NNH
(95% CI)
recent upper GI bleed due to ulcers or erosions, on long-term naproxen a single course of H.pylori eradication therapy regular omeprazole recurrent upper GI bleeding
at 6 months
4% 330%
(29% to 1400%)
8
(4 to 27)
history of peptic ulcer disease on long-term NSAIDs a single course of H.pylori eradication therapy regular pantoprazole severe gastrointestinal damage on endoscopy
at 4 weels
0%   4
(2 to 7)

 


Expiry date: July 2003
Levels of Evidence used in grading these guides

Author   A   Townsend , CM   Ball
Reviewer   L   Friedman
CAT Writers   A   Townsend , CM   Ball , CJ   Wotton